Detalhe da pesquisa
1.
Evolution in clinical presentation of inflammatory bowel disease over time at diagnosis: a multicenter cohort study.
Eur J Gastroenterol Hepatol
; 30(10): 1125-1129, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30004906
2.
Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission.
Clin Res Hepatol Gastroenterol
; 40(1): 90-8, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26138132
3.
Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study.
Dig Liver Dis
; 46(8): 695-700, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24893686
4.
Infliximab infusion time in patients with inflammatory bowel diseases: is longer really safer?
Clin Res Hepatol Gastroenterol
; 37(2): 189-92, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23246140
5.
Giant trichobezoar of duodenojejunal flexure: a rare entity.
Saudi J Gastroenterol
; 16(3): 215-7, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20616419